Pharmaceutical concerns amid opposition to TPP


Pharmaceutical concerns amid opposition to TPP
The United States and other Pacific Rim nations reached an agreement Monday on the Trans-Pacific Partnership (TPP) ,but the battle is far from over. Congress will review the deal over the next few months, and TPP is not without its critics. Zahara Heckscher is one of them. She’s a cancer patient who believes provisions of TPP would hinder the production of potentially life-saving generic drugs.
(Photo courtesy of Zahara Heckscher)